Kiora Pharmaceuticals Inc (KPRX)

Kiora Pharmaceuticals Inc (KPRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $10.9M; returns 1 day -1.3%, 1 week -4.6%, 1 year -9.8%.

Kiora Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing therapies for orphan retinal diseases with significant unmet medical needs. As a pre-revenue company, it currently generates income not from product sales, but through strategic partnerships and collaborations.

Groups KPRX belongs to

• Biotechnology
• Clinical Stage Biotech
• Ophthalmology
• Rare Diseases
• Healthcare
• Life Sciences
• Biopharmaceutical
• Clinical Stage
• Unmet Medical Needs
• Strategic Partnerships

KPRX financial model: income statement, cash flow and balance sheet